Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2011
03/17/2011US20110064654 Prostate cancer diagnosis and treatment
03/17/2011DE102009032645B3 Mikroröhren, umfassend Bestandteile der äußeren Membran von E. coli Zellen und rekombinant exprimierte S-Layer-Proteine, Verfahren zu ihrer Herstellung und Verwendung Microtubes, comprising constituents of the outer membrane of E. coli cells and recombinantly expressed S-layer proteins, processes for their preparation and use
03/17/2011CA2773886A1 Modulation of huntingtin expression
03/17/2011CA2773737A1 Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same
03/17/2011CA2773665A1 Improved pseudomonas exotoxin a with reduced immunogenicity
03/17/2011CA2773637A1 Combination vaccines against respiratory tract diseases
03/17/2011CA2773426A1 Use of interleukin-1 beta mutein conjugates in the treatment of diabetes
03/17/2011CA2773424A1 Hypoallergenic hybrid polypeptides for the treatment of allergy
03/17/2011CA2773192A1 Plgf-1 in homodimeric form
03/17/2011CA2772748A1 Molecules capable of inducing cell death by targeting the mitochondria and applications thereof
03/17/2011CA2771863A1 Compositions that induce t cell help
03/16/2011EP2295978A2 Early pregnancy diagnosis using PAGs(Pregnancy-associated Glycoproteins)
03/16/2011EP2295598A1 Method and kit for detection of cancer, and therapeutic agent for cancer
03/16/2011EP2295590A1 Nucleic acid sequences encoding proteins capable of associating into a virus-like particle
03/16/2011EP2295584A2 Transgenic plant-based methods for plant pests using RNAi
03/16/2011EP2295583A2 Method of plastid transformation in Asteraceae, vector for use therein and plants thus obtained
03/16/2011EP2295580A1 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides
03/16/2011EP2295577A2 Human cytokine as ligand of the z-alpha receptor and uses thereof
03/16/2011EP2295576A1 BMP-12, BMP-13 and tendon-inducing compositions thereof
03/16/2011EP2295575A2 Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
03/16/2011EP2295574A1 Human orphan G protein-coupled receptors
03/16/2011EP2295573A1 Human orphan G protein-coupled receptors
03/16/2011EP2295572A1 Human orphan G protein-coupled receptors
03/16/2011EP2295534A1 Novel microorganism and its use in lignocellulose detoxification
03/16/2011EP2295475A1 Polymer precursors of radiolabeled compounds, and methods of making and using the same
03/16/2011EP2295464A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
03/16/2011EP2295463A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
03/16/2011EP2295462A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
03/16/2011EP2295461A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
03/16/2011EP2295460A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
03/16/2011EP2295459A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
03/16/2011EP2295458A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
03/16/2011EP2295457A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
03/16/2011EP2295456A1 Albumin fusion proteins
03/16/2011EP2295455A1 Cytokine receptor
03/16/2011EP2295454A1 SLO2, a novel potassium channel protein from human brain
03/16/2011EP2295453A2 An appetite-suppressing peptide, its compositions and use
03/16/2011EP2295452A1 Glucagon-like-peptide-2 (GLP-2) analogues
03/16/2011EP2295451A1 Glucagon-like-peptide (GLP-2) analogues
03/16/2011EP2295449A1 PLGF-1 in homodimeric form
03/16/2011EP2295448A1 Sclerostin epitopes
03/16/2011EP2295447A1 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein
03/16/2011EP2295446A1 Generation of artificial binding proteins on the basis of ubiquitin-proteins
03/16/2011EP2295445A1 Aquaretic and natriuretic polypeptides lacking vasodilatory activity
03/16/2011EP2295443A1 Tumor-associated peptides which bind to MHC molecules
03/16/2011EP2295407A1 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
03/16/2011EP2295126A1 Method for purification of alpha-1-antitrypsin
03/16/2011EP2295086A1 Pancreatin and method of reducing the viral and microbial load of pancreatin
03/16/2011EP2295082A1 Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence
03/16/2011EP2295079A2 Method for treating inflammation
03/16/2011EP2295078A2 Method for treating inflammation
03/16/2011EP2295077A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
03/16/2011EP2295076A1 Hypoallergenic hybrid polypeptides for the treatment of allergy
03/16/2011EP2295075A1 Enterohemorragic escherichia coli vaccine
03/16/2011EP2295074A1 Anti-neovasculature preparations for treating cancer
03/16/2011EP2295073A1 Antibody against CD22 for the treatment of tumour of hematopoietic origin
03/16/2011EP2295071A1 Low dose methods for treating disorders in which TNF-alpha activity is detrimental
03/16/2011EP2295065A1 Modified heat shock protein-antigenic peptide complex
03/16/2011EP2295064A1 Monoclonal antibody therapy for pancreas cancer
03/16/2011EP2295060A2 Stabilization of hypoxia inducible factor (HIF) alpha
03/16/2011EP2295059A2 Stabilization of hypoxia inducible factor (HIF) alpha
03/16/2011EP2295023A1 Flavivirus vaccines
03/16/2011EP2294930A2 Expression of human milk proteins in transgenic plants
03/16/2011EP2294202A1 Soluble recombinant influenza antigens
03/16/2011EP2294200A1 Novel genes involved in biosynthesis
03/16/2011EP2294199A1 Compositions and methods for improving plants
03/16/2011EP2294197A2 Variant hhip1 protein and methods and uses thereof
03/16/2011EP2294192A2 Compositions and methods for dengue virus (dv) treatment and vaccination
03/16/2011EP2294191A2 Methods and compositions for generation of bax- and bak-deficient cell lines
03/16/2011EP2294183A2 Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage
03/16/2011EP2294086A2 Anti-inflammatory agents
03/16/2011EP2294083A2 Epitopes of il-17a and il-17f and antibodies specific thereto
03/16/2011EP2294082A1 Compositions and methods for modulating nicotinic/nmda receptor function
03/16/2011EP2294081A1 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function
03/16/2011EP2294080A2 N-glycosylated human growth hormone with prolonged circulatory half-life
03/16/2011EP2294079A2 Novel polypeptides related to b-type natriuretic peptides and methods of their identification and use
03/16/2011EP2294078A1 Rift valley fever virus-like particles and their use for immunization and as test system
03/16/2011EP2293811A1 Derivatised hybrid peptides of amylin and salmon calcitonin
03/16/2011EP2293810A2 Compositions and methods for preventing or treating aids
03/16/2011EP2293808A1 An synthetic peptide containing bone forming peptide 1(bfp 1) for stimulating osteoblast differentiation, and pharmaceutical composition comprising the synthetic peptide
03/16/2011EP2293804A1 Herpes simplex virus (hsv) with modified tropism, uses and process of preparation thereof
03/16/2011EP2293776A2 Functionally intact fibrinogen remaining stable during storage
03/16/2011EP2293685A1 Oilseed protein concentrates and isolates, and processes for the production thereof
03/16/2011EP2293678A1 Angiogenin-enriched milk fractions
03/16/2011EP2173890B1 Biological active proteins having increased in vivo and/or vitro stability
03/16/2011EP2118137B1 Peptides and polypeptides with improved stability useful in the regeneration of the nervous system
03/16/2011EP2102345B1 Rsv f-protein and use thereof
03/16/2011EP1877428B1 Cyanine- chlorotoxin conjugate and method for intra-operative visualization of cancer
03/16/2011EP1833507B1 Compositions for immunizing against mycobacterium
03/16/2011EP1812046B1 Melanocortin receptor binding mimetibodies, compositions, methods and uses
03/16/2011EP1682668B1 Plant transcriptional regulators
03/16/2011EP1436320B1 T cell epitopes of the cyn d 1 allergen from bermuda grass pollen
03/16/2011EP1359938B1 Method for treating psoriasis by using an il-17d antagonist
03/16/2011EP1248796B1 Process for the purification of antithrombin-iii
03/16/2011EP1135532B1 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
03/16/2011CN1660886B Process for crosslinking proteins with a ketose containing 3 to 5 carbon atoms
03/16/2011CN101985623A Cloning and application of key gene Wo for controlling tomato hair generation
03/16/2011CN101985470A Glucagon-like polypeptide-1 analog, preparation method and application thereof
03/16/2011CN101985469A Ruditapes philippinarum big defensin and preparation method and application thereof
03/16/2011CN101985468A SJ16 recombinant protein and application thereof in preparing schistosomiasis vaccine, diagnostic reagent and therapeutic drug